BioRestorative Therapies Inc reports results for the quarter ended June 30 - Earnings Summary

• BioRestorative Therapies Inc BRTX.OQ reported a quarterly adjusted loss of 30 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -50 cents. The mean expectation of two analysts for the quarter was for a loss of 38 cents per share. Wall Street expected results to range from -41 cents to -35 cents per share.

• Revenue rose 240.4% to $303.00 thousand from a year ago; analysts expected $340.00 thousand.

• BioRestorative Therapies Inc's reported EPS for the quarter was a loss of 30 cents​.

• The company reported a quarterly loss of $2.66 million.

• BioRestorative Therapies Inc shares had fallen by 15.3% this quarter and lost 1.4% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 11.8% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

• Wall Street's median 12-month price target for BioRestorative Therapies Inc is $13.00, about 89.2% above its last closing price of $1.41

This summary was machine generated from LSEG data August 12 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)